94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Xiaoyan Han1†Chunxiang Jin1†Gaofeng Zheng1Donghua He1
Yi Zhao1Yi Li1Wenjun Wu1Weiyan Zheng1Guoqing Wei1
Enfan Zhang1
He Huang1
Jingsong He1*‡
Zhen Cai1,2*‡- 1Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
- 2Institute of Hematology, Zhejiang University, Hangzhou, China
By Han X, Jin C, Zheng G, He D, Zhao Y, Li Y, Wu W, Zheng W, Wei G, Zhang E, Huang H, He J and Cai Z (2021). Front. Oncol. 11:665217. doi: 10.3389/fonc.2021.665217
There is an error in the title of the original article. The correct title is “Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: multiple myeloma, maintenance, proteasome inhibitors, immunomodulators, optimal maintenance duration
Citation: Han X, Jin C, Zheng G, He D, Zhao Y, Li Y, Wu W, Zheng W, Wei G, Zhang E, Huang H, He J and Cai Z (2021) Corrigendum: Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China. Front. Oncol. 11:740715. doi: 10.3389/fonc.2021.740715
Received: 13 July 2021; Accepted: 14 July 2021;
Published: 02 September 2021.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Han, Jin, Zheng, He, Zhao, Li, Wu, Zheng, Wei, Zhang, Huang, He and Cai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jingsong He, aGVqaW5nc29uZ0B6anUuZWR1LmNu; Zhen Cai, Y2FpekB6anUuZWR1LmNu
†These authors have contributed equally to this work and share first authorship
‡These authors have contributed equally to this work and share the last authorship